Insider · CIK 0002141644
Michele A. Anderson
Files at BRVE (Braveheart Bio, Inc.). First filing Aug 7, 2026, latest Aug 7, 2026.
In brief
Michele A. Anderson files SEC Form 4 as officer at BRVE (Braveheart Bio, Inc.). Since Aug 7, 2026, Michele A. Anderson has reported 1 open-market buy worth $20k and 0 open-market sells worth $0, the latest filed on Aug 7, 2026.
A track record needs three past buys with six months of prices behind them; Michele A. Anderson has 0, so none is measured yet.
The newest scored trade: bought $20k of BRVE on Aug 7, 2026, filed Aug 7, 2026, scored 25 (weak). In the last 12 months: 1 buy worth $20k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BRVE: Braveheart Bio, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | POpen-market purchase Common Stock | +1,111 | $18.00 | $20k | 332,161 | Aug 7, 2026 |
| Aug 5, 2026 | BRVE Braveheart Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Aug 7, 2026 |
Questions about Michele A. Anderson
Answered from the filings on this page, as of the latest one.
Is Michele A. Anderson buying or selling?
In the last 12 months Michele A. Anderson reported 1 open-market buy worth $20k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $20k of BRVE on Aug 7, 2026. Grants, option exercises and tax withholding are not counted.
How did Michele A. Anderson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michele A. Anderson has 0.
Where does Michele A. Anderson file Form 4?
Michele A. Anderson has filed Form 4 at BRVE (Braveheart Bio, Inc.) as Chief Development Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.